We've found
184,457
clinical trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Imaging of Solid Gastrointestinal Tumors Clinical Trial
A Phase I Study of MLN6907 in Patients With Metastatic Colorectal
Status: Enrolling,
Phase
I
Updated: 10/6/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant
Status: Enrolling,
Phase
I, II
Updated: 9/29/2017
Click here to add this to my saved trials
Carotid Stenosis Clinical Trial
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Carotid Stenosis Clinical Trial
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Carotid Stenosis Clinical Trial
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling,
Phase
III
Updated: 3/30/2016
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling,
Phase
III
Updated: 3/30/2016
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling,
Phase
III
Updated: 3/30/2016
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling,
Phase
III
Updated: 3/30/2016
Click here to add this to my saved trials
Post-polio Syndrome Clinical Trial
Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Differentiated Thyroid Cancer Clinical Trial
An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
Status: Enrolling
Updated: 3/15/2016
Click here to add this to my saved trials
Differentiated Thyroid Cancer Clinical Trial
An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
Status: Enrolling
Updated: 3/15/2016
Click here to add this to my saved trials
Differentiated Thyroid Cancer Clinical Trial
An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
Status: Enrolling
Updated: 3/15/2016
Click here to add this to my saved trials
Differentiated Thyroid Cancer Clinical Trial
An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
Status: Enrolling
Updated: 3/15/2016
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Head and Neck Squamous Cell Cancer Clinical Trial
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)
Status: Enrolling,
Phase
III
Updated: 4/7/2016
Click here to add this to my saved trials
Head and Neck Squamous Cell Cancer Clinical Trial
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)
Status: Enrolling,
Phase
III
Updated: 4/7/2016
Click here to add this to my saved trials
Head and Neck Squamous Cell Cancer Clinical Trial
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)
Status: Enrolling,
Phase
III
Updated: 4/7/2016
Click here to add this to my saved trials
Head and Neck Squamous Cell Cancer Clinical Trial
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)
Status: Enrolling,
Phase
III
Updated: 4/7/2016
Click here to add this to my saved trials
Head and Neck Squamous Cell Cancer Clinical Trial
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)
Status: Enrolling,
Phase
III
Updated: 4/7/2016
Click here to add this to my saved trials
Head and Neck Squamous Cell Cancer Clinical Trial
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)
Status: Enrolling,
Phase
III
Updated: 4/7/2016
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling,
Phase
II
Updated: 9/23/2015
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling,
Phase
II
Updated: 9/23/2015
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling,
Phase
II
Updated: 9/23/2015
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling,
Phase
II
Updated: 9/23/2015
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling,
Phase
II
Updated: 9/23/2015
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling,
Phase
II
Updated: 9/23/2015
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling,
Phase
II
Updated: 9/23/2015
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling,
Phase
II
Updated: 9/23/2015
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling,
Phase
II
Updated: 9/23/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Gastroparesis Clinical Trial
The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study
Status: Enrolling,
Phase
II
Updated: 12/12/2016
Click here to add this to my saved trials
Gastroparesis Clinical Trial
The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study
Status: Enrolling,
Phase
II
Updated: 12/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
Neurology Clinical Trial
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Study of Safety and Efficacy of EGFR-TKI EGF816 in Combination With cMET Inhibitor INC280 in Non-small Cell Lung Cancer Patients With EGFR Mutation.
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Lymphocytic Leukemia, Chronic Clinical Trial
A Study of GDC-0199 (ABT-199) in Combination With Obinutuzumab in Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
I
Updated: 1/12/2015
Click here to add this to my saved trials
Lymphocytic Leukemia, Chronic Clinical Trial
A Study of GDC-0199 (ABT-199) in Combination With Obinutuzumab in Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
I
Updated: 1/12/2015
Click here to add this to my saved trials
Lymphocytic Leukemia, Chronic Clinical Trial
A Study of GDC-0199 (ABT-199) in Combination With Obinutuzumab in Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
I
Updated: 1/12/2015
Click here to add this to my saved trials
Glioblastoma Multiforme Clinical Trial
Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas (INTELLANCE 2)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Glioblastoma Multiforme Clinical Trial
Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas (INTELLANCE 2)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Glioblastoma Multiforme Clinical Trial
Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas (INTELLANCE 2)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Apathy in Dementia Methylphenidate Trial 2
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Obstructive Pulmonary Disease Clinical Trial
Outcomes Data of Adipose Stem Cells to Treat Chronic Obstructive Pulmonary Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Safety and Efficacy of KTE-C19 in Adults With Refractory Aggressive Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Osteoarthritis of the Shoulder Clinical Trial
TITAN™ Reverse Shoulder System
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Dry Eye Syndromes Clinical Trial
A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye.
Status: Enrolling,
Phase
II, III
Updated: 7/30/2014
Click here to add this to my saved trials
Ureteral Stones Clinical Trial
Trial Comparing Relapse Rates Between Standard Ureteroscopic Removal Of Ureteral Stone And Standard Removal With Additional Ureterorenic Clearing Of Non-Symptomatic Stones In The Kidney
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients
Status: Enrolling,
Phase
II, III
Updated: 11/22/2016
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Patient-Centered Risk Adjusted Surveillance After Curative Resection of Colorectal Cancer
Status: Enrolling
Updated: 5/30/2017
Click here to add this to my saved trials
Gastroenterology, Pulmonary / Respiratory Diseases Clinical Trial
Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/11/2017
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
184,457
clinical trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Imaging of Solid Gastrointestinal Tumors Clinical Trial
Updated: 10/6/2015
A Phase I Study of MLN6907 in Patients With Metastatic Colorectal
Status: Enrolling,
Phase
I
Updated: 10/6/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 9/29/2017
Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant
Status: Enrolling,
Phase
I, II
Updated: 9/29/2017
Click here to add this to my saved trials
Carotid Stenosis Clinical Trial
Updated: 12/31/1969
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Carotid Stenosis Clinical Trial
Updated: 12/31/1969
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Carotid Stenosis Clinical Trial
Updated: 12/31/1969
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
Updated: 3/30/2016
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling,
Phase
III
Updated: 3/30/2016
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
Updated: 3/30/2016
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling,
Phase
III
Updated: 3/30/2016
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
Updated: 3/30/2016
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling,
Phase
III
Updated: 3/30/2016
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
Updated: 3/30/2016
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling,
Phase
III
Updated: 3/30/2016
Click here to add this to my saved trials
Post-polio Syndrome Clinical Trial
Updated: 12/31/1969
Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Differentiated Thyroid Cancer Clinical Trial
Updated: 3/15/2016
An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
Status: Enrolling
Updated: 3/15/2016
Click here to add this to my saved trials
Differentiated Thyroid Cancer Clinical Trial
Updated: 3/15/2016
An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
Status: Enrolling
Updated: 3/15/2016
Click here to add this to my saved trials
Differentiated Thyroid Cancer Clinical Trial
Updated: 3/15/2016
An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
Status: Enrolling
Updated: 3/15/2016
Click here to add this to my saved trials
Differentiated Thyroid Cancer Clinical Trial
Updated: 3/15/2016
An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
Status: Enrolling
Updated: 3/15/2016
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Head and Neck Squamous Cell Cancer Clinical Trial
Updated: 4/7/2016
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)
Status: Enrolling,
Phase
III
Updated: 4/7/2016
Click here to add this to my saved trials
Head and Neck Squamous Cell Cancer Clinical Trial
Updated: 4/7/2016
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)
Status: Enrolling,
Phase
III
Updated: 4/7/2016
Click here to add this to my saved trials
Head and Neck Squamous Cell Cancer Clinical Trial
Updated: 4/7/2016
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)
Status: Enrolling,
Phase
III
Updated: 4/7/2016
Click here to add this to my saved trials
Head and Neck Squamous Cell Cancer Clinical Trial
Updated: 4/7/2016
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)
Status: Enrolling,
Phase
III
Updated: 4/7/2016
Click here to add this to my saved trials
Head and Neck Squamous Cell Cancer Clinical Trial
Updated: 4/7/2016
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)
Status: Enrolling,
Phase
III
Updated: 4/7/2016
Click here to add this to my saved trials
Head and Neck Squamous Cell Cancer Clinical Trial
Updated: 4/7/2016
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)
Status: Enrolling,
Phase
III
Updated: 4/7/2016
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Updated: 9/23/2015
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling,
Phase
II
Updated: 9/23/2015
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Updated: 9/23/2015
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling,
Phase
II
Updated: 9/23/2015
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Updated: 9/23/2015
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling,
Phase
II
Updated: 9/23/2015
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Updated: 9/23/2015
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling,
Phase
II
Updated: 9/23/2015
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Updated: 9/23/2015
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling,
Phase
II
Updated: 9/23/2015
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Updated: 9/23/2015
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling,
Phase
II
Updated: 9/23/2015
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Updated: 9/23/2015
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling,
Phase
II
Updated: 9/23/2015
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Updated: 9/23/2015
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling,
Phase
II
Updated: 9/23/2015
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Updated: 9/23/2015
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling,
Phase
II
Updated: 9/23/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Updated: 9/23/2015
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Updated: 9/23/2015
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Updated: 9/23/2015
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Updated: 12/12/2016
The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study
Status: Enrolling,
Phase
II
Updated: 12/12/2016
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Updated: 12/12/2016
The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study
Status: Enrolling,
Phase
II
Updated: 12/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Updated: 4/12/2016
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Updated: 4/12/2016
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Updated: 4/12/2016
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Updated: 4/12/2016
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Updated: 4/12/2016
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Updated: 4/12/2016
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Updated: 4/12/2016
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Updated: 4/12/2016
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
HIV-1 Clinical Trial
Updated: 10/28/2015
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
HIV-1 Clinical Trial
Updated: 10/28/2015
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
HIV-1 Clinical Trial
Updated: 10/28/2015
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
HIV-1 Clinical Trial
Updated: 10/28/2015
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
Study of Safety and Efficacy of EGFR-TKI EGF816 in Combination With cMET Inhibitor INC280 in Non-small Cell Lung Cancer Patients With EGFR Mutation.
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Lymphocytic Leukemia, Chronic Clinical Trial
Updated: 1/12/2015
A Study of GDC-0199 (ABT-199) in Combination With Obinutuzumab in Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
I
Updated: 1/12/2015
Click here to add this to my saved trials
Lymphocytic Leukemia, Chronic Clinical Trial
Updated: 1/12/2015
A Study of GDC-0199 (ABT-199) in Combination With Obinutuzumab in Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
I
Updated: 1/12/2015
Click here to add this to my saved trials
Lymphocytic Leukemia, Chronic Clinical Trial
Updated: 1/12/2015
A Study of GDC-0199 (ABT-199) in Combination With Obinutuzumab in Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
I
Updated: 1/12/2015
Click here to add this to my saved trials
Glioblastoma Multiforme Clinical Trial
Updated: 12/31/1969
Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas (INTELLANCE 2)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Glioblastoma Multiforme Clinical Trial
Updated: 12/31/1969
Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas (INTELLANCE 2)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Glioblastoma Multiforme Clinical Trial
Updated: 12/31/1969
Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas (INTELLANCE 2)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
Apathy in Dementia Methylphenidate Trial 2
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Obstructive Pulmonary Disease Clinical Trial
Updated: 12/31/1969
Outcomes Data of Adipose Stem Cells to Treat Chronic Obstructive Pulmonary Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of KTE-C19 in Adults With Refractory Aggressive Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Osteoarthritis of the Shoulder Clinical Trial
Updated: 12/31/1969
TITAN™ Reverse Shoulder System
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Dry Eye Syndromes Clinical Trial
Updated: 7/30/2014
A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye.
Status: Enrolling,
Phase
II, III
Updated: 7/30/2014
Click here to add this to my saved trials
Ureteral Stones Clinical Trial
Updated: 12/31/1969
Trial Comparing Relapse Rates Between Standard Ureteroscopic Removal Of Ureteral Stone And Standard Removal With Additional Ureterorenic Clearing Of Non-Symptomatic Stones In The Kidney
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/22/2016
MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients
Status: Enrolling,
Phase
II, III
Updated: 11/22/2016
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Updated: 5/30/2017
Patient-Centered Risk Adjusted Surveillance After Curative Resection of Colorectal Cancer
Status: Enrolling
Updated: 5/30/2017
Click here to add this to my saved trials
Gastroenterology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 10/11/2017
Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/11/2017
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Updated: 12/31/1969
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Updated: 12/31/1969
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Updated: 12/31/1969
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Updated: 12/31/1969
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials